The fluorochemical intermediates market, according to FM, is likely to be reshaped less by aggregate volume growth and more by accelerated portfolio realignment toward compliance-ready, high-performance chemistries. As regulatory pressures force exit of legacy PFAS-linked intermediates, value creation is increasingly concentrated in low-GWP refrigerant building blocks, electronic-grade ultra-high-purity materials, battery-grade fluorinated salts, and pharmaceutical intermediates.